Cargando…
Deep learning model for virtual screening of novel 3C-like protease enzyme inhibitors against SARS coronavirus diseases
In the context of the recently emerging COVID-19 pandemic, we developed a deep learning model that can be used to predict the inhibitory activity of 3CLpro in severe acute respiratory syndrome coronavirus (SARS-CoV) for unknown compounds during the virtual screening process. This paper proposes a no...
Autores principales: | Kumari, Madhulata, Subbarao, Naidu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7935676/ https://www.ncbi.nlm.nih.gov/pubmed/33721736 http://dx.doi.org/10.1016/j.compbiomed.2021.104317 |
Ejemplares similares
-
High Throughput Virtual Screening to Identify Novel natural product Inhibitors for MethionyltRNA-Synthetase of Brucella melitensis
por: Kumari, Madhulata, et al.
Publicado: (2017) -
3D QSAR, pharmacophore and molecular docking studies of known inhibitors and designing of novel inhibitors for M18 aspartyl aminopeptidase of Plasmodium falciparum
por: Kumari, Madhulata, et al.
Publicado: (2016) -
Ultralarge
Virtual Screening Identifies SARS-CoV-2
Main Protease Inhibitors with Broad-Spectrum Activity against Coronaviruses
por: Luttens, Andreas, et al.
Publicado: (2022) -
Virtual Screening for Identification of Dual Inhibitors against CDK4/6 and Aromatase Enzyme
por: Adon, Tenzin, et al.
Publicado: (2023) -
Molecular Analysis and Modeling of Hepatitis E Virus Helicase and Identification of Novel Inhibitors by Virtual Screening
por: Parvez, Mohammad K., et al.
Publicado: (2018)